Heidi Hamm

Using computer-aided drug design, Heidi Hamm, Craig Lindsley, and Jens Meiler and their labs generated a novel series of biologically active compounds that can serve as a basis for anti–blood clot preventative drugs. Read More

Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes. Read More

Ege Kavalali and Heidi Hamm collaborated to discover a signaling pathway for how spontaneous release of neurotransmitters can be selectively regulated without disrupting evoked action potentials. Read More

Emmanuele DiBenedetto, a retired mathematics professor who made significant contributions to the understanding of partial differential equations, has died after a 15-month struggle with cancer. Read More

Biochemistry professor Fred Guengerich and pharmacology professor Heidi Hamm have been named part of the inaugural class of fellows of the American Society for Biochemistry and Molecular Biology. The newly established honor recognizes the most distinguished members of this professional society. Read More

Heidi Hamm and colleagues have reported the first animal model of a "shut-off valve" for neurotransmitter and hormone release through SNARE complex-mediated membrane fusion. Read More

Seven outstanding Ph.D.’s with diverse backgrounds and experiences have come to Vanderbilt to pursue postdoctoral training with an eye toward academic careers. Read More

Vanderbilt investigators have discovered how antidepressant medicines that block serotonin uptake can increase bleeding risk. Read More

Heidi Hamm, a world leader in G protein signaling, is the recipient of the 2015 Robert R. Ruffolo Career Achievement Award in Pharmacology. Read More

Vanderbilt's Heidi Hamm, Ph.D., and L. Jackson Roberts II, M.D., have been lauded by the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read More

Heidi Hamm, Ph.D. In their introductions of Heidi Hamm, Ph.D., prior to her Flexner Discovery Lecture last week, Susan Wente, Ph.D., and P. Jeffrey Conn, Ph.D., recounted how early encounters with her influenced their careers. For Wente, associate vice chancellor for… Read More

During her 13-year tenure as chair of Vanderbilt University’s Department of Pharmacology, Heidi Hamm, Ph.D., bolstered its international reputation, attracted 18 new faculty members and helped take it in new directions, such as drug discovery. Read More

Heidi Hamm, Ph.D., the Aileen M. Lange and Annie Mary Lyle Professor of Cardiovascular Research and an internationally known expert on G protein-mediated signaling, will deliver the next Flexner Discovery Lecture on Thursday, June 12. Read More

Thanks in part to a computer program named “Rosetta,” Vanderbilt University researchers are closer to understanding how the ubiquitous G protein is activated – a discovery that could lead to the design of more specific and effective drugs. Read More

Heidi Hamm, Ph.D., chair of the Department of Pharmacology, has won the 2012 Ariens Award from the Dutch Pharmacological Society. Read More

Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners. Read More

Twelve Vanderbilt University faculty members were honored for extraordinary contributions to their respective fields during an Aug. 28 celebration of endowed chair holders at the Student Life Center. Read More

Fourteen Vanderbilt researchers have been elected fellows of the American Association for the Advancement of Science (AAAS). Read More

Researchers have discovered how key proteins are “turned on” and transmit signals inside the cell. The discovery could lead to new, more effective drugs. Read More